NEVVI Medicare utilization intelligence

← back

HAVARD, ROBERTMD NPI 1225002694 Clinician

Hematology-Oncology · VISALIA, CA

Specialty Hematology-Oncology — from billed Medicare claims
Trained UNIVERSITY OF CALIFORNIA, GEFFEN SCHOOL OF MEDICINE — medical school, self-reported to CMS
In practice about 46 years since medical school (class of 1980, self-reported to CMS)
Location VISALIA, CA · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 39 codes billed · 51,158 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
KAWEAH DELTA HEALTH CARE DISTRICT
2026
SEQUOIA ONCOLOGY MEDICAL ASSOC
2019–2024

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2023-03

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Unlock to see the figure.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J9263 Injection, oxaliplatin, 0.5 mg
J9271 Injection, pembrolizumab, 1 mg
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units
J1453 Injection, fosaprepitant, 1 mg
J0897 Injection, denosumab, 1 mg
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units
J1100 Injection, dexamethasone sodium phosphate, 1 mg
Q5126 Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
J1626 Injection, granisetron hydrochloride, 100 mcg
J2469 Injection, palonosetron hcl, 25 mcg
36415 Insertion of needle into vein for collection of blood sample
Q5130 Injection, pegfilgrastim-pbbk (fylnetra), biosimilar, 0.5 mg
96372 Injection of drug or substance under skin or into muscle
96413 Administration of chemotherapy into vein, 1 hour or less
96375 Injection of additional new drug or substance into vein
J9045 Injection, carboplatin, 50 mg
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
J0640 Injection, leucovorin calcium, per 50 mg
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
J3490 Unclassified drugs
96415 Administration of chemotherapy into vein, each additional hour
J1200 Injection, diphenhydramine hcl, up to 50 mg
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
J3489 Injection, zoledronic acid, 1 mg
96417 Administration of additional new drug or substance into vein, 1 hour or less
J3315 Injection, triptorelin pamoate, 3.75 mg
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
99195 Drawing of blood for a medical problem
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)
96523 Irrigation of implanted venous access drug delivery device
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
J1454 Injection, fosnetupitant 235 mg and palonosetron 0.25 mg
96360 Infusion into a vein for hydration, 31-60 minutes
J7030 Infusion, normal saline solution , 1000 cc
96361 Infusion into a vein for hydration, each additional hour

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.